OTTAWA, July 31, 2012 /CNW/ - Health Canada is informing Canadians that it is assessing the possibility of an increased risk of cancer with long-term use of the drug calcitonin. Calcitonin is a ...
WEST LAFAYETTE, Ind. – A novel form of a drug used to treat osteoporosis that comes with the potential for fewer side effects may provide a new option for patients. Purdue University innovators ...
Data showed oral drug licensed from Unigene was as good as nasal spray calcitonin at improving BMD. Tarsa Therapeutics reported positive data from a Phase III study evaluating its once-daily oral ...
WASHINGTONA panel of health experts who advise the Food and Drug Administration says a long-established bone strengthening inhalable drug calcitonin salmon should no longer be taken by women. The ...
July 20, 2012 — The European equivalent of the US Food and Drug Administration (FDA) yesterday recommended withdrawing calcitonin nasal spray — indicated for treating osteoporosis in the European ...
Staff reviewers for the U.S. Food and Drug Administration said that a potential increased risk of cancer with drugs containing calcitonin salmon appears plausible. In briefing documents released on ...
A therapeutics company has raised $28 million in a series B financing round in the run-up to submitting its new drug application later this year for its oral calcitonin remedy to treat and cure ...
CGRP antagonists are a new class of drugs designed to prevent migraine headaches by targeting a key molecule involved in pain transmission. Calcitonin gene-related peptide (CGRP) monoclonal antibodies ...
Think your bones stopped growing by the time you finished high school? Think again. Bones constantly remodel themselves throughout life, growing here, thinning there. In osteoporosis, though, normal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback